TipRanks
Mayne Pharma Group (MAYNF)
OTHER OTC:MAYNF
US Market
MAYNF
Mayne Pharma Group
RESEARCH TOOLSreports

Mayne Pharma Group (MAYNF) Income Statement

24 Followers

Mayne Pharma Group Income Statement

Last quarter (Q4 2026), Mayne Pharma Group's total revenue was AU$171.61M, a decrease of -14.40% from the same quarter last year. In Q4, Mayne Pharma Group's net income was AU$39.41M. See Mayne Pharma Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 26Jun 25Jun 24Jun 23Jun 22
Total Revenue
AU$ 383.68MAU$ 408.10MAU$ 388.15MAU$ 183.59MAU$ 157.15M
Gross Profit
AU$ 192.21MAU$ 247.27MAU$ 218.53MAU$ 26.84MAU$ 23.75M
Operating Expenses
AU$ 226.49MAU$ 270.87MAU$ 357.59MAU$ 213.28MAU$ 145.62M
Depreciation and Amortization
AU$ 63.69MAU$ 64.11MAU$ 68.46MAU$ 65.44MAU$ 55.18M
EBITDA
AU$ 29.40MAU$ 42.08MAU$ -116.93MAU$ -193.80MAU$ -78.88M
Operating Income
AU$ -34.28MAU$ -23.59MAU$ -139.06MAU$ -186.44MAU$ -121.88M
Other Income/Expenses
AU$ 70.04MAU$ -59.70MAU$ -51.02MAU$ -83.25MAU$ -23.71M
Pretax Income
AU$ 35.76MAU$ -83.30MAU$ -190.09MAU$ -269.70MAU$ -145.59M
Net Income
AU$ 24.47MAU$ -93.84MAU$ -174.23MAU$ 117.25MAU$ -281.29M
Per Share Metrics
Basic EPS
AU$ 0.31AU$ -1.14AU$ -2.19AU$ -3.89AU$ -3.46
Diluted EPS
AU$ 0.21AU$ -1.14AU$ -2.19AU$ -3.89AU$ -3.46
Weighted Average Shares Outstanding
 79.94M 79.14M 79.62M 81.25M 81.25M
Weighted Average Shares Outstanding (Diluted)
 106.29M 79.14M 79.62M 81.25M 81.25M
Currency in AUD

Mayne Pharma Group Earnings and Revenue History